315
Views
0
CrossRef citations to date
0
Altmetric
ERRATUM

Erratum

Pages 1420-1421 | Published online: 12 Oct 2012
This article refers to:
Suppression of indomethacin-induced apoptosis in the small intestine due to Bach1 deficiency

In the article entitled “Suppression of indomethacin-induced apoptosis in the small intestine due to Bach1 deficiency” by Akihito Harusato et al. published in the June 2011 issue of Free Radical Research (Free radic res 2011; 45: 717–727 DOI: 10.3109/10715762.2011.574287) errors have been identified that we would like to make our readers aware of.

In the text part ‘Protein extraction and Western blotting’, ‘20mg of total protein’ should be ‘20μg of total protein’.

and have switched places. In , ‘Snpp + +‘ should be ‘Snpp − +‘

The correct figures are shown below.

The corresponding author and Informa Healthcare apologise for this error and sincerely regret any inconvenience this may have caused our readers.

Figure 9. (A) The apoptotic score was calculated by counting 10 randomly selected villi and crypts in the sections after the TUNEL staining. The score represents the means of TUNEL-positive cells. Data were compared by Student's t-test for unpaired variance and each value indicates the mean ± SEM for three mice. *p < 0.05 compared to Bach1-deficient mice treated with indomethacin only. (B) Activation of caspase-3 in Bach 1-deficient mice treated with indomethacin was analyzed using an anti-active caspase-3 antibody in the cytosolic fractions of mucosal homogenates by western blotting. Each treatment condition is represented by two lanes.

Figure 9. (A) The apoptotic score was calculated by counting 10 randomly selected villi and crypts in the sections after the TUNEL staining. The score represents the means of TUNEL-positive cells. Data were compared by Student's t-test for unpaired variance and each value indicates the mean ± SEM for three mice. *p < 0.05 compared to Bach1-deficient mice treated with indomethacin only. (B) Activation of caspase-3 in Bach 1-deficient mice treated with indomethacin was analyzed using an anti-active caspase-3 antibody in the cytosolic fractions of mucosal homogenates by western blotting. Each treatment condition is represented by two lanes.

Figure 10. (A) Activation of caspase-3 was analysed using an anti-active caspase-3 antibody in the cytosolic fractions of mucosal homogenates by western blotting. Each treatment condition is represented by two lanes. (B) The densitometric data of western blotting for cleaved caspase-3. Data were compared by ANOVA followed by Bonferroni's Multiple Comparison Test and each value indicates the mean ± SEM of six mice. *p < 0.05 compared to the wild type mice treated with indomethacin. #p < 0.05 compared to the wild-type mice, vehicle.

Figure 10. (A) Activation of caspase-3 was analysed using an anti-active caspase-3 antibody in the cytosolic fractions of mucosal homogenates by western blotting. Each treatment condition is represented by two lanes. (B) The densitometric data of western blotting for cleaved caspase-3. Data were compared by ANOVA followed by Bonferroni's Multiple Comparison Test and each value indicates the mean ± SEM of six mice. *p < 0.05 compared to the wild type mice treated with indomethacin. #p < 0.05 compared to the wild-type mice, vehicle.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.